How I Manage CLL and Multiple Sclerosis A CLL patient advocate who also has multiple sclerosis (MS), Andy shares his story during Patient Power’s recent town meeting in Denver. After two rounds of treatment—first with FCR (fludarabine, cyclophosphamide, rituximab) and now in a clinical trial with ibrutinib (Imbruvica)—Andy discusses his advice for living well. Get email alerts | Subscribe on YouTube | Like on Facebook | Follow on Twitter | Follow on Google+ |